Benzodiazepines and Related Sedatives.
Peng L, Morford KL, Levander XA.
Med Clin North Am. 2022 Jan;106(1):113-129. doi: 10.1016/j.mcna.2021.08.012.
Melatonin and its analogs in insomnia and depression.
Cardinali DP, Srinivasan V, Brzezinski A, Brown GM.
J Pineal Res. 2012 May;52(4):365-75. doi: 10.1111/j.1600-079X.2011.00962.x. Epub 2011 Sep 23.
Benzodiazepine harm: how can it be reduced?
Lader M.
Br J Clin Pharmacol. 2014 Feb;77(2):295-301. doi: 10.1111/j.1365-2125.2012.04418.x.
Insomnia in older adults: A review of treatment options.
León-Barriera R, Chaplin MM, Kaur J, Modesto-Lowe V.
Cleve Clin J Med. 2025 Jan 2;92(1):43-50. doi: 10.3949/ccjm.92a.24073.
Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.
Mayo-Smith MF.
JAMA. 1997 Jul 9;278(2):144-51. doi: 10.1001/jama.278.2.144.
Therapeutics development for addiction: Orexin-1 receptor antagonists.
Perrey DA, Zhang Y.
Brain Res. 2020 Mar 15;1731:145922. doi: 10.1016/j.brainres.2018.08.025. Epub 2018 Aug 24.
Zolpidem-related euphoria, addiction and detoxification: A case report and review of the literature.
Xie F, Liu B, Yang L, Huang J, Li B, Li Y.
Medicine (Baltimore). 2024 Nov 1;103(44):e40280. doi: 10.1097/MD.0000000000040280.
[Appropriate Use and Abuse of Sedative-Hypnotic Drugs].
Zheng JW, Meng SQ, Liu WY, Chang XW, Shi J.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):231-239. doi: 10.12182/20230260302.
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System.
Fragale JE, James MH, Avila JA, Spaeth AM, Aurora RN, Langleben D, Aston-Jones G.
Front Neurol Neurosci. 2021;45:117-127. doi: 10.1159/000514965. Epub 2021 May 28.
Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?".
James MH, Aston-Jones G.
Brain Res. 2020 Mar 15;1731:146665. doi: 10.1016/j.brainres.2020.146665. Epub 2020 Jan 10.
